5. Network effect estimates and ranking statistics for necrotizing enterocolitis.

Ibuprofen Mean SUCRA, 0.69; median rank, 1 (95% CrI, 1‐3)
0.96 ( 0.40, 2.55)	Indomethacin Mean SUCRA, 0.66; median rank, 2 (95% CrI, 1‐3)
0.73 (0.31, 1.4)	0.76 (0.35, 1.2)	Placebo Mean SUCRA, 0.15; median rank, 3 (95% CrI, 2‐3)

The unlabeled data in the boxes are risk ratios (RRs) and 95% credible intervals (CrIs). A RR >1 suggests that the upper left treatment is associated with a higher risk of having the outcome of interest vs the corresponding lower right treatment and the opposite is true for an RR <1. SUCRA, surface under the cumulative ranking curve